Alexey Alexeyevich Tinkov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alexey Alexeyevich Tinkov has a total of 550 co-authors. Here are the top co-authors by number of shared publications:
- Anatoly Viktorovich Skalny
RUDN University
103 shared publications Anatoly V. Skalny
76 shared publications- Margarita G. Skalnaya
Peoples' Friendship University of Russia (RUDN University), Moscow, Russia
51 shared publications Michael Aschner
40 shared publications- Alexandr Nikonorov
State Research Center of Dermatovenereology and Cosmetology
27 shared publications - Michael Aschner
Department of Molecular Pharmacology, Albert Einstein College of Medicine
27 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Elsevier in SSRN Electronic Journal
Mechanisms by which salidroside alleviates methylmercury-induced toxicity: insights by network toxicology and molecular docking
Background and Objective Methylmercury (MeHg) is a widely present environmental neurotoxin that poses significant risks to global health, but effective detoxification strategies are still very limited due to insufficient understanding of its complex molecular pathogenesis. Although plant derived adaptogen salidroside (SAL) has shown promise in counteracting methylmercury induced neurotoxicity, its potential mechanism remains largely unclear. In this situation, a system level approach is urgently needed. Therefore, this study adopted a network toxicology framework that combines multiple omics data to systematically decipher the protective mechanism of SAL against methylmercury, aiming to identify new targeted pathways and accelerate the discovery of mechanism based antidotes.,Methods Firstly, putative target genes of SAL were predicted by the CTD database and Swiss Target Prediction and SEA analysis platform. Next, target genes associated with MeHg toxicity were collected from GeneCards and CTD databases. The species was selected as ”Homo sapiens”, and the Uniprot website was used to convert the target gene names to standardized gene names. Common target genes were obtained after data screening. Then, the above cross genes were imported into the String website to construct the protein-protein interaction (PPI) network, and further analyzed the gene ontology (GO) functional annotation and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. Finally, molecular docking and molecular dynamics simulations were conducted to verify the possible binding conformations between SAL and the candidate targets.,Results A total of 239 target genes for SAL and 913 target genes for MeHg were identified. Thirty seven common target genes were identified. By GO/KEGG analysis, it was shown that pharmacological effects of SAL on MeHg toxicity was associated with antioxidant, anti-hypoxia, anti-apoptosis and anti-inflammatory signaling pathways. Molecular docking and molecular dynamics simulations further confirmed that SAL had good binding activity with AKT1 and HIF1A.,Conclusion The potential mechanism of SAL in alleviating MeHg-induced toxicity may be attributed to the specific effects of SAL on AKT1 and HIF1A.
- 20 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessMechanisms by which salidroside alleviates methylmercury-induced toxicity: insights by network toxicology and molecular docking
Background and Objective Methylmercury (MeHg) is a widely present environmental neurotoxin that poses significant risks to global health, but effective detoxification strategies are still very limited due to insufficient understanding of its complex molecular pathogenesis. Although plant derived adaptogen salidroside (SAL) has shown promise in counteracting methylmercury induced neurotoxicity, its potential mechanism remains largely unclear. In this situation, a system level approach is urgently needed. Therefore, this study adopted a network toxicology framework that combines multiple omics data to systematically decipher the protective mechanism of SAL against methylmercury, aiming to identify new targeted pathways and accelerate the discovery of mechanism based antidotes.,Methods Firstly, putative target genes of SAL were predicted by the CTD database and Swiss Target Prediction and SEA analysis platform. Next, target genes associated with MeHg toxicity were collected from GeneCards and CTD databases. The species was selected as ”Homo sapiens”, and the Uniprot website was used to convert the target gene names to standardized gene names. Common target genes were obtained after data screening. Then, the above cross genes were imported into the String website to construct the protein-protein interaction (PPI) network, and further analyzed the gene ontology (GO) functional annotation and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. Finally, molecular docking and molecular dynamics simulations were conducted to verify the possible binding conformations between SAL and the candidate targets.,Results A total of 239 target genes for SAL and 913 target genes for MeHg were identified. Thirty seven common target genes were identified. By GO/KEGG analysis, it was shown that pharmacological effects of SAL on MeHg toxicity was associated with antioxidant, anti-hypoxia, anti-apoptosis and anti-inflammatory signaling pathways. Molecular docking and molecular dynamics simulations further confirmed that SAL had good binding activity with AKT1 and HIF1A.,Conclusion The potential mechanism of SAL in alleviating MeHg-induced toxicity may be attributed to the specific effects of SAL on AKT1 and HIF1A.
- Open Access
- 8 October 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 283
Nrf2 and STAT3 Pathways in Protecting Against Methylmercury-Induced Oxidative Stress in Hypothalamic Neuronal GT1-7 Cells
Oxidative stress plays a critical role in the methylmercury (MeHg) neurotoxicity, as MeHg induces reactive oxygen species (ROS) generation and impairs antioxidant defense systems. However, the precise molecular mechanisms underlying MeHg-induced neurotoxicity remain elusive. The nuclear factor erythroid 2-related factor 2 (Nrf2) activates antioxidant defense genes in response to acute MeHg exposure. Similarly, the signal transducer and activator of transcription 3 (STAT3), a transcription factor involved in cell growth and anti-apoptotic genes, also contributes to maintaining redox homeostasis. Here, we sought to investigate the roles of Nrf2 and STAT3 in mouse hypothalamic neuronal GT1-7 cells exposed to MeHg. We inhibited STAT3 either pharmacologically with AG490 (a JAK2 inhibitor) or C188-9 (a small-molecule STAT3 SH2 domain inhibitor) or genetically using a lentivirus carrying STAT3 shRNA (vs. scramble control), in GT1-7 cells exposed to 5 µM MeHg. To further dissect the role of Nrf2, the pathway was pharmacologically inhibited using brusatol or activated with sulforaphane (SFN) in GT1-7 cells co-exposed to 5 µM MeHg. Changes in cell viability, reactive species production, and protein and gene expression were analyzed. Our findings reveal that deficits of either the Nrf2 or STAT3 pathways exacerbated MeHg-induced toxicity. Moreover, in MeHg-exposed cells, Nrf2 ablation led to increased STAT3 activity, suggesting a reciprocal and potentially compensatory responses between these two pathways in protecting against MeHg-induced oxidative stress. Our novel findings provide crucial understanding of the molecular mechanisms underlying MeHg neurotoxicity and offer insights into potential therapeutic strategies for mitigating acute MeHg-induced neurotoxicity. Graphical Abstract
- 8 October 2026
- Published by Springer Nature in Neurochemical Research
- Vol. 51 (5) , 283
Open AccessNrf2 and STAT3 Pathways in Protecting Against Methylmercury-Induced Oxidative Stress in Hypothalamic Neuronal GT1-7 Cells
Oxidative stress plays a critical role in the methylmercury (MeHg) neurotoxicity, as MeHg induces reactive oxygen species (ROS) generation and impairs antioxidant defense systems. However, the precise molecular mechanisms underlying MeHg-induced neurotoxicity remain elusive. The nuclear factor erythroid 2-related factor 2 (Nrf2) activates antioxidant defense genes in response to acute MeHg exposure. Similarly, the signal transducer and activator of transcription 3 (STAT3), a transcription factor involved in cell growth and anti-apoptotic genes, also contributes to maintaining redox homeostasis. Here, we sought to investigate the roles of Nrf2 and STAT3 in mouse hypothalamic neuronal GT1-7 cells exposed to MeHg. We inhibited STAT3 either pharmacologically with AG490 (a JAK2 inhibitor) or C188-9 (a small-molecule STAT3 SH2 domain inhibitor) or genetically using a lentivirus carrying STAT3 shRNA (vs. scramble control), in GT1-7 cells exposed to 5 µM MeHg. To further dissect the role of Nrf2, the pathway was pharmacologically inhibited using brusatol or activated with sulforaphane (SFN) in GT1-7 cells co-exposed to 5 µM MeHg. Changes in cell viability, reactive species production, and protein and gene expression were analyzed. Our findings reveal that deficits of either the Nrf2 or STAT3 pathways exacerbated MeHg-induced toxicity. Moreover, in MeHg-exposed cells, Nrf2 ablation led to increased STAT3 activity, suggesting a reciprocal and potentially compensatory responses between these two pathways in protecting against MeHg-induced oxidative stress. Our novel findings provide crucial understanding of the molecular mechanisms underlying MeHg neurotoxicity and offer insights into potential therapeutic strategies for mitigating acute MeHg-induced neurotoxicity. Graphical Abstract
- 8 September 2026
- Published by Springer Nature in Biological Trace Element Research
- p. 1-19
Selenium, Selenoprotein P, and Gut Dysbiosis are Associated with Cartilage Damage in Osteoarthritis Patients
The objective of the present study was to evaluate markers of selenium (Se) metabolism and taxonomic characteristics of gut microbiota, as well as their relationship to markers of inflammation and cartilage damage in patients with osteoarthritis (OA). The study enrolled 50 healthy controls, 45 patients with knee OA (kOA), and 41 patients with knee and one-sided hip OA (khOA). Serum selenoprotein P (SELENOP), cartilage oligomeric matrix protein (COMP), lipopolysaccharide (LPS), C-reactive protein (CRP), as well as C3 and C5a complement components were assessed. Serum, hair, and urinary Se levels were evaluated using inductively coupled plasma-mass spectrometry (ICP-MS). Fecal microbiota taxonomy was evaluated by high-throughput sequencing. Patients with kOA and especially khOA were characterized by higher COMP and CRP levels. LPS concentration also tended to be higher in khOA patients. The lowest serum Se and SELENOP levels were observed in khOA patients. The richness of Bacteroidota phylum, classes Bacteroidia and Negativicutes was increased, whereas the abundance of Coriobacteriia was lower in OA patients compared to controls. The relative abundance of families Actinomycetaceae, Anaerovoracaceae, Clostridiaceae, Eggerthellaceae, Lactobacillaceae, Peptostreptococcaceae, Streptococcaceae, and unclassified_Clostridia UCG-014 was reduced in OA patients, while Oscillospiraceae and Prevotellaceae were enriched. Significant group differences were also observed in the richness of certain bacterial genera. Multiple linear regression analysis revealed inverse association between SELENOP and LPS concentrations, while COMP concentration was associated with C5a and SELENOP levels in a positive and negative manner, respectively. Certain bacterial taxa were also considered significant predictors of SELENOP and COMP levels. Therefore, these novel data establish that gut dysbiosis is associated with both cartilage damage and altered Se metabolism in OA.
- 8 September 2026
- Published by Springer Nature in Biological Trace Element Research
- p. 1-19
Selenium, Selenoprotein P, and Gut Dysbiosis are Associated with Cartilage Damage in Osteoarthritis Patients
The objective of the present study was to evaluate markers of selenium (Se) metabolism and taxonomic characteristics of gut microbiota, as well as their relationship to markers of inflammation and cartilage damage in patients with osteoarthritis (OA). The study enrolled 50 healthy controls, 45 patients with knee OA (kOA), and 41 patients with knee and one-sided hip OA (khOA). Serum selenoprotein P (SELENOP), cartilage oligomeric matrix protein (COMP), lipopolysaccharide (LPS), C-reactive protein (CRP), as well as C3 and C5a complement components were assessed. Serum, hair, and urinary Se levels were evaluated using inductively coupled plasma-mass spectrometry (ICP-MS). Fecal microbiota taxonomy was evaluated by high-throughput sequencing. Patients with kOA and especially khOA were characterized by higher COMP and CRP levels. LPS concentration also tended to be higher in khOA patients. The lowest serum Se and SELENOP levels were observed in khOA patients. The richness of Bacteroidota phylum, classes Bacteroidia and Negativicutes was increased, whereas the abundance of Coriobacteriia was lower in OA patients compared to controls. The relative abundance of families Actinomycetaceae, Anaerovoracaceae, Clostridiaceae, Eggerthellaceae, Lactobacillaceae, Peptostreptococcaceae, Streptococcaceae, and unclassified_Clostridia UCG-014 was reduced in OA patients, while Oscillospiraceae and Prevotellaceae were enriched. Significant group differences were also observed in the richness of certain bacterial genera. Multiple linear regression analysis revealed inverse association between SELENOP and LPS concentrations, while COMP concentration was associated with C5a and SELENOP levels in a positive and negative manner, respectively. Certain bacterial taxa were also considered significant predictors of SELENOP and COMP levels. Therefore, these novel data establish that gut dysbiosis is associated with both cartilage damage and altered Se metabolism in OA.
- Open Access
- 21 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7476
Novel Cerium Phosphate–Citric Acid Nanocomposites for Biomedical Applications in Regenerative Medicine: In Vitro and In Vivo Study
The aim of the study was to synthesize nanocomposites based on cerium orthophosphate stabilized with citrate at different ratios for biomedical applications, and to evaluate its safety in different animal species. Nanocomposites were synthesized using four different initial mass ratios of Ce(NO3)3 × 6H2O to citric acid: 1:5 (Ce:5CA), 1:3 (Ce:3CA), 1:1 (Ce:1CA), and 1:0.5 (Ce:0.5CA). The obtained products were characterized by a series of physicochemical methods including X-ray diffraction, transmission electron microscopy, and IR spectroscopy. Biomedical studies of the sols were performed to evaluate redox activity and their effects on the metabolism and proliferation of human fibroblasts. Safety studies were carried out in different animal species, including determination of the acute toxicity of the selected nanocomposite following application to intact skin and intragastric administration, as well as determination of subchronic toxicity using a model of acute experimental full-thickness skin wounds. According to the physicochemical studies, all synthesized nanocomposites contained nanocrystals with bimodal dimensions (width 3–10 nm, length 15–40 nm) and diffraction peaks characteristic of CePO4. IR spectroscopy demonstrated the formation of new chemical bonds. Antioxidant activity was observed for the Ce:3CA, Ce:1CA, and Ce:0.5CA samples, being most pronounced for Ce:1–0.5CA, whose antioxidant capacity exceeded that of ascorbic acid. In contrast, Ce:5CA exhibited pro-oxidant activity at all tested concentrations. Biocompatibility with human cells was demonstrated. Ce:0.5CA was identified as the most promising candidate for biomedical applications owing to its highest regenerative and antioxidant potential and its demonstrated safety in animals following topical and intragastric administration, as well as in wound models. Histomorphological examination of the internal organs supported the safety and potential of the developed nanocomposites for skin regeneration and wound healing.
- 21 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7476
Open AccessNovel Cerium Phosphate–Citric Acid Nanocomposites for Biomedical Applications in Regenerative Medicine: In Vitro and In Vivo Study
The aim of the study was to synthesize nanocomposites based on cerium orthophosphate stabilized with citrate at different ratios for biomedical applications, and to evaluate its safety in different animal species. Nanocomposites were synthesized using four different initial mass ratios of Ce(NO3)3 × 6H2O to citric acid: 1:5 (Ce:5CA), 1:3 (Ce:3CA), 1:1 (Ce:1CA), and 1:0.5 (Ce:0.5CA). The obtained products were characterized by a series of physicochemical methods including X-ray diffraction, transmission electron microscopy, and IR spectroscopy. Biomedical studies of the sols were performed to evaluate redox activity and their effects on the metabolism and proliferation of human fibroblasts. Safety studies were carried out in different animal species, including determination of the acute toxicity of the selected nanocomposite following application to intact skin and intragastric administration, as well as determination of subchronic toxicity using a model of acute experimental full-thickness skin wounds. According to the physicochemical studies, all synthesized nanocomposites contained nanocrystals with bimodal dimensions (width 3–10 nm, length 15–40 nm) and diffraction peaks characteristic of CePO4. IR spectroscopy demonstrated the formation of new chemical bonds. Antioxidant activity was observed for the Ce:3CA, Ce:1CA, and Ce:0.5CA samples, being most pronounced for Ce:1–0.5CA, whose antioxidant capacity exceeded that of ascorbic acid. In contrast, Ce:5CA exhibited pro-oxidant activity at all tested concentrations. Biocompatibility with human cells was demonstrated. Ce:0.5CA was identified as the most promising candidate for biomedical applications owing to its highest regenerative and antioxidant potential and its demonstrated safety in animals following topical and intragastric administration, as well as in wound models. Histomorphological examination of the internal organs supported the safety and potential of the developed nanocomposites for skin regeneration and wound healing.
- Open Access
- 7 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1526
Completeness of MMR Vaccination and Durability of Vaccine-Induced Antibody Responses in Children with Inflammatory Bowel Disease
Background: Children with IBD are at increased risk of suboptimal maintenance of vaccine-induced immunity, particularly when the MMR vaccination course is incomplete before diagnosis and initiation of immunosuppressive therapy. We conducted a prospective study to evaluate the durability of antibody responses to measles, mumps, and rubella in pediatric IBD patients and to determine how completeness of MMR vaccination influences long-term antibody persistence over 12 months. Methods: Sixty children with IBD were included. Demographic characteristics, clinical disease activity (PUCAI/PCDAI), inflammatory markers (CRP, ESR), and fecal calprotectin were extracted from electronic medical records. Vaccination completeness was ascertained from documented immunization history. Serum antibodies to measles, rubella, and mumps were measured at baseline and after 12 months. Seroprotection was defined using standard laboratory thresholds. Antibody decay over time was assessed with paired non-parametric tests, and time to loss of seroprotection was analyzed using Cox proportional hazards models. In addition, Bayesian ANOVA modeling was applied to quantify evidence for differences in antibody concentrations and decay kinetics according to vaccination status. Results: Overall, 66.7% of patients had completed the full MMR vaccination course. At baseline, seroprotection rates were 48.3% for measles, 76.7% for rubella, and 70% for mumps. After 12 months, median antibody concentrations declined significantly for all three antigens. Corresponding seroprotection rates changed to 46.7% for measles (p = 0.414), 70% for rubella (p = 0.046), and 66.7% for mumps (p = 0.157). Incomplete MMR vaccination was identified as a major modifiable risk factor for accelerated antibody waning in children with IBD. Cox regression demonstrated that incompletely vaccinated patients had a 2.13-fold higher risk of losing measles seroprotection (95% CI 1.07–4.24; p = 0.032), a 5.27-fold higher risk for rubella (95% CI 1.86–14.95; p = 0.002), and a 4.82-fold higher risk for mumps (95% Cl 1.68–13.85; p = 0.004). Bayesian analyses provided decisive evidence that vaccination completeness strongly influences baseline antibody levels. Conclusions: Incomplete MMR vaccination is associated with markedly reduced durability of vaccine-induced immunity to measles, mumps, and rubella in children with IBD. These findings underscore the need for systematic prevaccination screening, timely completion of age-appropriate vaccination before initiation of immunosuppressive therapy when feasible, and individualized serological monitoring to identify patients at highest risk of vaccine-preventable infections.
- 7 July 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (7) , 1526
Open AccessCompleteness of MMR Vaccination and Durability of Vaccine-Induced Antibody Responses in Children with Inflammatory Bowel Disease
Background: Children with IBD are at increased risk of suboptimal maintenance of vaccine-induced immunity, particularly when the MMR vaccination course is incomplete before diagnosis and initiation of immunosuppressive therapy. We conducted a prospective study to evaluate the durability of antibody responses to measles, mumps, and rubella in pediatric IBD patients and to determine how completeness of MMR vaccination influences long-term antibody persistence over 12 months. Methods: Sixty children with IBD were included. Demographic characteristics, clinical disease activity (PUCAI/PCDAI), inflammatory markers (CRP, ESR), and fecal calprotectin were extracted from electronic medical records. Vaccination completeness was ascertained from documented immunization history. Serum antibodies to measles, rubella, and mumps were measured at baseline and after 12 months. Seroprotection was defined using standard laboratory thresholds. Antibody decay over time was assessed with paired non-parametric tests, and time to loss of seroprotection was analyzed using Cox proportional hazards models. In addition, Bayesian ANOVA modeling was applied to quantify evidence for differences in antibody concentrations and decay kinetics according to vaccination status. Results: Overall, 66.7% of patients had completed the full MMR vaccination course. At baseline, seroprotection rates were 48.3% for measles, 76.7% for rubella, and 70% for mumps. After 12 months, median antibody concentrations declined significantly for all three antigens. Corresponding seroprotection rates changed to 46.7% for measles (p = 0.414), 70% for rubella (p = 0.046), and 66.7% for mumps (p = 0.157). Incomplete MMR vaccination was identified as a major modifiable risk factor for accelerated antibody waning in children with IBD. Cox regression demonstrated that incompletely vaccinated patients had a 2.13-fold higher risk of losing measles seroprotection (95% CI 1.07–4.24; p = 0.032), a 5.27-fold higher risk for rubella (95% CI 1.86–14.95; p = 0.002), and a 4.82-fold higher risk for mumps (95% Cl 1.68–13.85; p = 0.004). Bayesian analyses provided decisive evidence that vaccination completeness strongly influences baseline antibody levels. Conclusions: Incomplete MMR vaccination is associated with markedly reduced durability of vaccine-induced immunity to measles, mumps, and rubella in children with IBD. These findings underscore the need for systematic prevaccination screening, timely completion of age-appropriate vaccination before initiation of immunosuppressive therapy when feasible, and individualized serological monitoring to identify patients at highest risk of vaccine-preventable infections.
- 3 July 2026
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (10) , 7592-7624
The Protective Effects of Selenium Nanoparticles Against Metal Toxicity
The objective of the present review is to discuss the protective effects of SeNPs against metal toxicity with special emphasis on the underlying mechanisms and efficacy of SeNPs in comparison to other Se species. In vivo and in vitro studies show that SeNPs mitigate the adverse effects of metal(loid)s (cadmium, lead, arsenic, aluminum, etc.), metal nanoparticles (silver, cobalt), as well as platinum-based agent cisplatin in brain, liver, kidneys, heart, intestine, and gonads. SeNPs substantially reduce toxic metal accumulation in the organism, thus attenuating their toxicity. In metal-exposed animals, SeNPs enhance the biosynthesis of selenoproteins (including GPX4) and up-regulate Nrf2 signaling, thus inhibiting oxidative stress and ferroptosis. Anti-inflammatory effect of SeNPs was shown to be mediated by inhibition of NF-κB and MAPKs, as well as activation of PI3K/Akt signaling. Inhibition of metal-induced endoplasmic reticulum stress and improvement of autophagy also underlies the protective effects of SeNPs. Neuroprotective effects of SeNPs were shown to be mediated by inhibition of metal-induced increase in amyloid β and Tau protein accumulation and aggregation. The majority of studies show that SeNPs possess stronger protective effect against metal toxicity compared to sodium selenite or organoselenium compounds. Furthermore, the beneficial effects of SeNPs in metal-exposed animals were significantly increased by combined administration or surface modifications with bioactive molecules. Taken together, these findings show that SeNPs possess protective effects against metal toxicity through a variety of mechanisms, although their potential efficacy in treatment metal intoxication in humans has yet to be determined.
- 3 July 2026
- Published by Springer Nature in Biological Trace Element Research
- Vol. 204 (10) , 7592-7624
The Protective Effects of Selenium Nanoparticles Against Metal Toxicity
The objective of the present review is to discuss the protective effects of SeNPs against metal toxicity with special emphasis on the underlying mechanisms and efficacy of SeNPs in comparison to other Se species. In vivo and in vitro studies show that SeNPs mitigate the adverse effects of metal(loid)s (cadmium, lead, arsenic, aluminum, etc.), metal nanoparticles (silver, cobalt), as well as platinum-based agent cisplatin in brain, liver, kidneys, heart, intestine, and gonads. SeNPs substantially reduce toxic metal accumulation in the organism, thus attenuating their toxicity. In metal-exposed animals, SeNPs enhance the biosynthesis of selenoproteins (including GPX4) and up-regulate Nrf2 signaling, thus inhibiting oxidative stress and ferroptosis. Anti-inflammatory effect of SeNPs was shown to be mediated by inhibition of NF-κB and MAPKs, as well as activation of PI3K/Akt signaling. Inhibition of metal-induced endoplasmic reticulum stress and improvement of autophagy also underlies the protective effects of SeNPs. Neuroprotective effects of SeNPs were shown to be mediated by inhibition of metal-induced increase in amyloid β and Tau protein accumulation and aggregation. The majority of studies show that SeNPs possess stronger protective effect against metal toxicity compared to sodium selenite or organoselenium compounds. Furthermore, the beneficial effects of SeNPs in metal-exposed animals were significantly increased by combined administration or surface modifications with bioactive molecules. Taken together, these findings show that SeNPs possess protective effects against metal toxicity through a variety of mechanisms, although their potential efficacy in treatment metal intoxication in humans has yet to be determined.
- Open Access
- 30 June 2026
- Published by European Publishing in Public Health and Toxicology
- Vol. 6 (2) , 1-8
Serum arsenic and lead levels are associated with lung damage and inflammation in COVID-19 patients
- 30 June 2026
- Published by European Publishing in Public Health and Toxicology
- Vol. 6 (2) , 1-8
Open AccessSerum arsenic and lead levels are associated with lung damage and inflammation in COVID-19 patients
- 23 June 2026
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 96, 127918
Neurotoxicity of antimony: A review of epidemiological evidence and the underlying molecular mechanisms
- 23 June 2026
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 96, 127918
Neurotoxicity of antimony: A review of epidemiological evidence and the underlying molecular mechanisms
- Open Access
- 12 May 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (5) , 47103
Molecular Mechanisms of Manganese Oxide Nanoparticles Toxicity in Brain and Other Tissues: An Overview
The use of manganese oxide nanoparticles (MnOxNPs) in biomedicine increases the risk of their accumulation in the body, potentially leading to toxicity in various organs and tissues. In addition, occupational exposure to MnOxNPs-containing aerosols may also occur. MnOxNPs have been shown to accumulate in the brain and induce neurobehavioral alterations. However, the specific mechanisms of MnOxNPs toxicity in the brain and other tissues remain incompletely understood. Therefore, the objective of this review is to summarize existing data on the toxicity of MnOxNPs in the brain and other tissues, and to discuss the molecular mechanisms underlying their neurotoxic effects. It has been shown that MnOxNPs induce neuronal death through induction of mitochondrial dysfunction and subsequent apoptosis, and overaccumulation of tau protein and amyloid-β. Neurotoxic effects of MnOxNPs may also be mediated by blood–brain barrier disruption, and dysregulation of dopaminergic and glutaminergic signaling. Exposure to MnOxNPs induces neuroinflammation through activation of nuclear factor kappa B (NF-κB) and p38 mitogen-activated protein kinase (p38 MAPK) pathways in a reactive oxygen species-dependent manner. In vitro studies further demonstrate that MnOxNPs exhibit a dose-dependent cytotoxic effects in alveolar macrophages, as well as in respiratory, colonic, and other epithelial cells, through the promotion of oxidative stress and an inflammatory response. Overexposure to MnOxNPs has significant nephrotoxic, hepatotoxic, and immunotoxic effects, as well as affecting the reproductive system. Smaller particles exhibit more pronounced toxic effects in the brain and other tissues than larger nanoparticles or microparticles. However, the mechanisms underlying the different toxicities of MnOxNPs of different sizes, shapes, and surface modifications remain unclear. These observations highlight the potential of MnOxNP exposure to contribute to neurological disorders and dysfunction of other systems, underscoring the need for further mechanistic studies to ensure their safe application in biomedicine.
- 12 May 2026
- Published by IMR Press in Frontiers in Bioscience-Landmark
- Vol. 31 (5) , 47103
Open AccessMolecular Mechanisms of Manganese Oxide Nanoparticles Toxicity in Brain and Other Tissues: An Overview
The use of manganese oxide nanoparticles (MnOxNPs) in biomedicine increases the risk of their accumulation in the body, potentially leading to toxicity in various organs and tissues. In addition, occupational exposure to MnOxNPs-containing aerosols may also occur. MnOxNPs have been shown to accumulate in the brain and induce neurobehavioral alterations. However, the specific mechanisms of MnOxNPs toxicity in the brain and other tissues remain incompletely understood. Therefore, the objective of this review is to summarize existing data on the toxicity of MnOxNPs in the brain and other tissues, and to discuss the molecular mechanisms underlying their neurotoxic effects. It has been shown that MnOxNPs induce neuronal death through induction of mitochondrial dysfunction and subsequent apoptosis, and overaccumulation of tau protein and amyloid-β. Neurotoxic effects of MnOxNPs may also be mediated by blood–brain barrier disruption, and dysregulation of dopaminergic and glutaminergic signaling. Exposure to MnOxNPs induces neuroinflammation through activation of nuclear factor kappa B (NF-κB) and p38 mitogen-activated protein kinase (p38 MAPK) pathways in a reactive oxygen species-dependent manner. In vitro studies further demonstrate that MnOxNPs exhibit a dose-dependent cytotoxic effects in alveolar macrophages, as well as in respiratory, colonic, and other epithelial cells, through the promotion of oxidative stress and an inflammatory response. Overexposure to MnOxNPs has significant nephrotoxic, hepatotoxic, and immunotoxic effects, as well as affecting the reproductive system. Smaller particles exhibit more pronounced toxic effects in the brain and other tissues than larger nanoparticles or microparticles. However, the mechanisms underlying the different toxicities of MnOxNPs of different sizes, shapes, and surface modifications remain unclear. These observations highlight the potential of MnOxNP exposure to contribute to neurological disorders and dysfunction of other systems, underscoring the need for further mechanistic studies to ensure their safe application in biomedicine.
- 5 May 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 435, 112136
The protective effects of selenium on mitochondrial quality under exogenous and endogenous stressors
- 5 May 2026
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 435, 112136
The protective effects of selenium on mitochondrial quality under exogenous and endogenous stressors